Relaxin-3 systems in brain: validation of neural targets and functional roles

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/509246

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Our laboratory recently discovered the brain 'transmitter' called 'relaxin-3', and are researching how it affects brain activity and animal physiology and behaviour. Findings suggest that relaxin-3 can modulate memory, responses to stress and other complex behaviours. Identifying the various actions of relaxin-3 in the brain could provide potential new treatments for conditions such as anxiety-depression, cognitive deficits (dementia) and schizophrenia.

Funded Activity Details

Start Date: 01-01-2008

End Date: 01-01-2010

Funding Scheme: NHMRC Project Grants

Funding Amount: $537,579.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Medical infection agents (incl. prions)

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

Animal model - behaviour - memory - stress | Gene regulation - gene knock-out | Neuroanatomy - brainstem - hippocampus | Neuropeptides - G-protein coupled receptors - pharmacology | Relaxin - insulin-like peptides | anxiety and mood disorders | cognitive deficits-dysfunction | gene structure protein function novel drug therapies | neurochemistry - neuropharmacology | neuropeptides - mental health

Related Links